Key Elements on the Pathway to HCV Elimination: Lessons Learned From the AASLD HCV Special Interest Group 2020

Jordan J. Feld, John W. Ward – 2 May 2021 – With a decade left to reach the ambitious goals for viral hepatitis elimination set out by the World Health Organization, many challenges remain. Despite the remarkable improvements in therapy for hepatitis C virus (HCV) infection, most people living with the infection remain undiagnosed, and only a fraction have received curative therapy.

What Survivorship Means to Liver Transplant Recipients: Qualitative Groundwork for a Survivorship Conceptual Model

Sarah R. Lieber, Hannah P. Kim, Luke Baldelli, Rebekah Nash, Randall Teal, Gabrielle Magee, Marci M. Loiselle, Chirag S. Desai, Simon C. Lee, Amit G. Singal, Jorge A. Marrero, A. Sidney Barritt, Donna M. Evon – 2 May 2021 – Survivorship is a well‐established concept in the cancer care continuum with a focus on disease recurrence, quality of life, and the minimization of competing risks for mortality; however, survivorship has not been well studied in liver transplantation (LT).

Hepatic Small Ubiquitin‐Related Modifier (SUMO)–Specific Protease 2 Controls Systemic Metabolism Through SUMOylation‐Dependent Regulation of Liver–Adipose Tissue Crosstalk

Yang Liu, Xin Dou, Wei‐yu Zhou, Meng Ding, Ling Liu, Ruo‐qi Du, Liang Guo, Shu‐wen Qian, Yan Tang, Qi‐qi Yang, Dong‐ning Pan, Xiao‐ying Li, Yan Lu, Jin‐ke Cheng, Qi‐qun Tang – 1 May 2021

Subscribe to